395 related articles for article (PubMed ID: 29987703)
21. The N-terminal, polybasic region of PrP(C) dictates the efficiency of prion propagation by binding to PrP(Sc).
Turnbaugh JA; Unterberger U; Saá P; Massignan T; Fluharty BR; Bowman FP; Miller MB; Supattapone S; Biasini E; Harris DA
J Neurosci; 2012 Jun; 32(26):8817-30. PubMed ID: 22745483
[TBL] [Abstract][Full Text] [Related]
22. Styryl-based and tricyclic compounds as potential anti-prion agents.
Chung E; Prelli F; Dealler S; Lee WS; Chang YT; Wisniewski T
PLoS One; 2011; 6(9):e24844. PubMed ID: 21931860
[TBL] [Abstract][Full Text] [Related]
23. Chemically induced accumulation of GAGs delays PrP(Sc) clearance but prolongs prion disease incubation time.
Mayer-Sonnenfeld T; Avrahami D; Friedman-Levi Y; Gabizon R
Cell Mol Neurobiol; 2008 Nov; 28(7):1005-15. PubMed ID: 18350378
[TBL] [Abstract][Full Text] [Related]
24. Prion protein facilitates retinal iron uptake and is cleaved at the β-site: Implications for retinal iron homeostasis in prion disorders.
Asthana A; Baksi S; Ashok A; Karmakar S; Mammadova N; Kokemuller R; Greenlee MH; Kong Q; Singh N
Sci Rep; 2017 Aug; 7(1):9600. PubMed ID: 28851903
[TBL] [Abstract][Full Text] [Related]
25. Modulation of proteinase K-resistant prion protein in cells and infectious brain homogenate by redox iron: implications for prion replication and disease pathogenesis.
Basu S; Mohan ML; Luo X; Kundu B; Kong Q; Singh N
Mol Biol Cell; 2007 Sep; 18(9):3302-12. PubMed ID: 17567949
[TBL] [Abstract][Full Text] [Related]
26. The Size and Stability of Infectious Prion Aggregates Fluctuate Dynamically during Cellular Uptake and Disaggregation.
Shoup D; Priola SA
Biochemistry; 2021 Feb; 60(5):398-411. PubMed ID: 33497187
[TBL] [Abstract][Full Text] [Related]
27. Mouse prion protein (PrP) segment 100 to 104 regulates conversion of PrP(C) to PrP(Sc) in prion-infected neuroblastoma cells.
Hara H; Okemoto-Nakamura Y; Shinkai-Ouchi F; Hanada K; Yamakawa Y; Hagiwara K
J Virol; 2012 May; 86(10):5626-36. PubMed ID: 22398286
[TBL] [Abstract][Full Text] [Related]
28. The tyrosine kinase inhibitor STI571 induces cellular clearance of PrPSc in prion-infected cells.
Ertmer A; Gilch S; Yun SW; Flechsig E; Klebl B; Stein-Gerlach M; Klein MA; Schätzl HM
J Biol Chem; 2004 Oct; 279(40):41918-27. PubMed ID: 15247213
[TBL] [Abstract][Full Text] [Related]
29. Cytoskeleton-dependent clustering of membrane-bound prion protein on the cell surface.
Hackl S; Ng XW; Lu D; Wohland T; Becker CFW
J Biol Chem; 2021; 296():100359. PubMed ID: 33539927
[TBL] [Abstract][Full Text] [Related]
30. Transition of the prion protein from a structured cellular form (PrP
Baral PK; Yin J; Aguzzi A; James MNG
Protein Sci; 2019 Dec; 28(12):2055-2063. PubMed ID: 31583788
[TBL] [Abstract][Full Text] [Related]
31. Pressure-assisted dissociation and degradation of "proteinase K-resistant" fibrils prepared by seeding with scrapie-infected hamster prion protein.
Akasaka K; Maeno A; Murayama T; Tachibana H; Fujita Y; Yamanaka H; Nishida N; Atarashi R
Prion; 2014; 8(4):314-8. PubMed ID: 25482603
[TBL] [Abstract][Full Text] [Related]
32. Comparative profiling of highly enriched 22L and Chandler mouse scrapie prion protein preparations.
Moore RA; Timmes A; Wilmarth PA; Priola SA
Proteomics; 2010 Aug; 10(15):2858-69. PubMed ID: 20518029
[TBL] [Abstract][Full Text] [Related]
33. Calpain-dependent endoproteolytic cleavage of PrPSc modulates scrapie prion propagation.
Yadavalli R; Guttmann RP; Seward T; Centers AP; Williamson RA; Telling GC
J Biol Chem; 2004 May; 279(21):21948-56. PubMed ID: 15026410
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of PLK3 Mediates the Degradation of Abnormal Prion Proteins Dependent on Chaperone-Mediated Autophagy.
Wang H; Tian C; Sun J; Chen LN; Lv Y; Yang XD; Xiao K; Wang J; Chen C; Shi Q; Shao QX; Dong XP
Mol Neurobiol; 2017 Aug; 54(6):4401-4413. PubMed ID: 27344333
[TBL] [Abstract][Full Text] [Related]
35. Prion infection impairs lysosomal degradation capacity by interfering with rab7 membrane attachment in neuronal cells.
Shim SY; Karri S; Law S; Schatzl HM; Gilch S
Sci Rep; 2016 Feb; 6():21658. PubMed ID: 26865414
[TBL] [Abstract][Full Text] [Related]
36. Strategies for eliminating PrP(c) as substrate for prion conversion and for enhancing PrP(Sc) degradation.
Gilch S; Nunziante M; Ertmer A; Schätzl HM
Vet Microbiol; 2007 Aug; 123(4):377-86. PubMed ID: 17493775
[TBL] [Abstract][Full Text] [Related]
37. Efficient in vitro amplification of a mouse-adapted scrapie prion protein.
Murayama Y; Yoshioka M; Yokoyama T; Iwamaru Y; Imamura M; Masujin K; Yoshiba S; Mohri S
Neurosci Lett; 2007 Feb; 413(3):270-3. PubMed ID: 17174030
[TBL] [Abstract][Full Text] [Related]
38. PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection.
Marshall KE; Hughson A; Vascellari S; Priola SA; Sakudo A; Onodera T; Baron GS
J Virol; 2017 Jan; 91(2):. PubMed ID: 27847358
[TBL] [Abstract][Full Text] [Related]
39. Anti-PrP antibodies block PrPSc replication in prion-infected cell cultures by accelerating PrPC degradation.
Perrier V; Solassol J; Crozet C; Frobert Y; Mourton-Gilles C; Grassi J; Lehmann S
J Neurochem; 2004 Apr; 89(2):454-63. PubMed ID: 15056288
[TBL] [Abstract][Full Text] [Related]
40. Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication.
Nunziante M; Kehler C; Maas E; Kassack MU; Groschup M; Schätzl HM
J Cell Sci; 2005 Nov; 118(Pt 21):4959-73. PubMed ID: 16219680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
